S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,116.57 +0.34%
Next Bullish Trade
Sign in
BAYRY

Bayer Aktiengesellschaft OQX · BAYRY

$13.80 +0.20 (+1.47%)
Extended · +1.34σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BAYRY

Momentum reads · latest daily bar
Last
$13.80
+0.20 (+1.47%)
Mkt cap
$54.2B
Healthcare
RSI(14)
61.7
neutral
Stochastic %K
41.6
neutral
MFI(14)
40.1
neutral
ADX(14)
31.5
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $13.4B $2.8B $3.5B $-2.2B 20.6% 26.3%
2025-12-31 $11.4B $-3.8B $4.3B $3.4B -32.8% 38.0%
2025-09-30 $9.7B $-1.0B $-0.5B $0.8B -10.0% -5.6%
2025-06-30 $10.7B $-0.2B $0.0B $0.6B -1.9% 0.1%
2025-03-31 $13.7B $1.3B $2.3B $-1.4B 9.5% 16.9%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BAYRY vs peers

Line BAYRY up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BAYRY AVGO× GOOG× TSLA× PFE×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + TMO
Popular + AAPL + MSFT + NVDA + AMZN + META
Verdict
Weighted score 0-100 across 5 tickers · best in green
#3
BAYRY
score 57.0
5/5 inputs
Dominates momentum with perfect 100 score but crippled by sentiment at 9, yielding third-place overall rank.
value 80growth 50quality 20momentum 100sentiment 9
#2
AVGO
score 62.0
5/5 inputs
Exceptional growth score of 89 with 47.9% revenue growth offset by weak momentum at 17, securing second place.
value 60growth 89quality 75momentum 17sentiment 67
#1
GOOG
score 64.8
5/5 inputs
Leads with outstanding quality score of 90 driven by 38.9% ROE and low 0.2 debt-to-equity ratio.
value 69growth 61quality 90momentum 44sentiment 66
#5
TSLA
score 16.2
5/5 inputs
Catastrophic value score of 7 from 346 trailing P/E ratio drags overall performance to distant fifth place.
value 7growth 26quality 26momentum 9sentiment 17
#4
PFE
score 41.6
5/5 inputs
Abysmal growth score of 8 from negative 10.1% EPS growth undermines strong value metrics for fourth-place finish.
value 83growth 8quality 48momentum 30sentiment 38
BAYRY
Bayer Aktiengesellschaft
$13.80
+1.47%
Snapshot
Price 13.8
Day % 1.47
1M % 32.95
3M % 16.95
YTD % 24.44
Market cap 54229807104.0
ADV ($) 19244983.465991974
Beta 0.83
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 4.01
Dist ATR (σ) 1.34
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm)
P/E (fwd) 11.139633
P/S 1.1986607
EV/EBITDA 8.523
P/B 1.6485983
FCF yield 0.1349
PEG 4.61
Growth
Revenue yoy -0.024
EPS yoy 1.129
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.59918
Operating margin 0.26319
Net margin -0.04765
ROE -0.06928
ROA 0.03637
Debt / Equity 1.34
Interest cov. -0.38
Technicals
RSI(14) 61.7
MACD signal neutral
vs 50-DMA 17.38
vs 200-DMA 26.78
vs 52w high -9.39
HV-30 59.0
Sentiment
Analyst rec 2.25
Target upside 10.33
Insider buy-sell 90d
Risk
Short interest
Days to cover 0.0
Next earnings 2026-08-04
Full BAYRY dashboard →
AVGO
Broadcom Inc.
$370.83
-0.97%
Snapshot
Price 370.83
Day % -0.97
1M % -1.56
3M % -6.94
YTD % 6.68
Market cap 1764229775360.0
ADV ($) 9716734651.767548
Beta 1.462
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.79
Dist ATR (σ) -0.84
OdysseyHQ grade
Confluence 2
Valuation
P/E (ttm) 61.701332
P/E (fwd) 19.098053
P/S 23.37812
EV/EBITDA 42.998
P/B 20.120728
FCF yield 0.0154
PEG 0.42
Growth
Revenue yoy 0.479
EPS yoy 0.854
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.76284
Operating margin 0.48988
Net margin 0.38848
ROE 0.37280998
ROA 0.121190004
Debt / Equity 0.74
Interest cov. 8.08
Technicals
RSI(14) 43.8
MACD signal neutral
vs 50-DMA -7.97
vs 200-DMA 1.98
vs 52w high -25.08
HV-30 66.2
Sentiment
Analyst rec 1.3125
Target upside 41.44
Insider buy-sell 90d -43
Risk
Short interest 1.5
Days to cover 1.9
Next earnings 2026-09-03
Full AVGO dashboard →
GOOG
Alphabet Inc.
$346.12
-2.17%
Snapshot
Price 346.12
Day % -2.17
1M % -6.73
3M % 4.01
YTD % 9.77
Market cap 4223554551808.0
ADV ($) 7507971248.00293
Beta 1.247
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.01
Dist ATR (σ) -0.94
OdysseyHQ grade C
Confluence 3
Valuation
P/E (ttm) 26.381098
P/E (fwd) 23.627647
P/S 9.996626
EV/EBITDA 25.804
P/B 8.759427
FCF yield 0.0066
PEG 1.39
Growth
Revenue yoy 0.218
EPS yoy 0.82
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.60368
Operating margin 0.36121
Net margin 0.37919
ROE 0.38884997
ROA 0.14641
Debt / Equity 0.2
Interest cov. 216.8
Technicals
RSI(14) 43.3
MACD signal neutral
vs 50-DMA -5.94
vs 200-DMA 7.84
vs 52w high -14.43
HV-30 36.1
Sentiment
Analyst rec 1.43077
Target upside 23.59
Insider buy-sell 90d
Risk
Short interest
Days to cover 2.13
Next earnings 2026-07-22
Full GOOG dashboard →
TSLA
Tesla, Inc.
$380.84
-2.61%
Snapshot
Price 380.84
Day % -2.61
1M % -5.89
3M % -2.07
YTD % -13.06
Market cap 1430329884672.0
ADV ($) 18811567626.19034
Beta 1.802
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -4.52
Dist ATR (σ) -1.07
OdysseyHQ grade
Confluence 2
Valuation
P/E (ttm) 346.21817
P/E (fwd) 149.10927
P/S 14.613246
EV/EBITDA 126.389
P/B 17.392338
FCF yield 0.0037
PEG 4.77
Growth
Revenue yoy 0.158
EPS yoy 0.083
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.19065
Operating margin 0.04203
Net margin 0.03946
ROE 0.04901
ROA 0.022330001
Debt / Equity 0.19
Interest cov. 16.62
Technicals
RSI(14) 42.6
MACD signal bear
vs 50-DMA -7.07
vs 200-DMA -8.68
vs 52w high -23.65
HV-30 57.9
Sentiment
Analyst rec 2.38298
Target upside 11.65
Insider buy-sell 90d -19
Risk
Short interest 2.3699999
Days to cover 1.66
Next earnings 2026-07-22
Full TSLA dashboard →
PFE
PFE
$25.05
-0.36%
Snapshot
Price 25.05
Day % -0.36
1M % -3.8
3M % -7.97
YTD % -0.52
Market cap 142771077120.0
ADV ($) 1037779234.0927048
Beta 0.307
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.53
Dist ATR (σ) 0.7
OdysseyHQ grade
Confluence 0
Valuation
P/E (ttm) 19.122137
P/E (fwd) 8.8405
P/S 2.2549329
EV/EBITDA 7.648
P/B 1.5844401
FCF yield 0.0867
PEG 2.96
Growth
Revenue yoy 0.054
EPS yoy -0.101
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.74801004
Operating margin 0.31617
Net margin 0.118310004
ROE 0.083100006
ROA 0.05687
Debt / Equity 0.72
Interest cov. 3.82
Technicals
RSI(14) 53.6
MACD signal neutral
vs 50-DMA -0.88
vs 200-DMA -3.23
vs 52w high -12.87
HV-30 23.5
Sentiment
Analyst rec 2.46429
Target upside 14.92
Insider buy-sell 90d 16
Risk
Short interest 2.87
Days to cover 3.45
Next earnings 2026-08-04
Full PFE dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-11 0.79 0.62 +29.1% +3.0%
2026-03-03 0.18 0.16 +13.5% +0.4%
2025-11-11 0.17 0.13 +30.9% +5.7%
2025-08-06 0.36 0.25 +43.4% +2.1%
2025-05-13 0.70 0.69 +0.4% -10.0%
2025-03-04 0.28 0.26 +4.8% +6.5%
2024-11-12 0.06 0.17 -62.1% -3.9%
2024-08-06 0.26 0.25 +1.2% +1.0%
2024-05-12 0.76 0.42 +80.1% +1.3%
2024-03-04 0.50 0.45 +10.6% -7.7%
2023-11-08 0.10 0.27 -62.7% +0.2%
2023-08-08 0.34 0.31 +6.6% -0.3%
2023-05-11 0.81 0.54 +48.7% +0.0%
2023-02-28 0.36 0.33 +8.6% +1.1%
2022-11-08 0.28 0.22 +29.5% -3.8%
2022-08-04 0.49 0.50 -1.9% -7.1%
2022-05-10 0.93 0.77 +21.0% -8.0%
2022-03-01 0.35 0.27 +32.8% +3.9%
2021-11-09 0.30 0.30 +0.6% +0.1%
2021-08-05 0.48 0.47 +2.2% +0.2%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BAYRY $54B 11.1 1.2 8.5 1.6 59.9% -2.4% 112.9% 13.49%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 0.17%

HolderShares% out
Kahn Brothers Group Inc. 6,513,893 0.17%
Westside Investment Management, Inc. 2,878
PNC Financial Services Group, Inc. 3,030
Atlas Capital Advisors Inc 35,510
Great Lakes Advisors LLC 119,517
Rhumbline Advisers 68,123
Salomon & Ludwin, LLC 2,141
Gamma Investing LLC 41,204
Chicago Trust Co Na 20,097
Sterling Capital Management, LLC 846

Insider activity · 90d

No insider trades for BAYRY in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$14.5
Mean
$15.225
High
$15.8
Analysts
4
Recommendation distribution · period 2026-07-01
6
15
7
Revision trend (2026-04-01 → 2026-07-01): net 19 → 21 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

No CIK found for BAYRY.

About BAYRY

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmaci…

Options picks · BAYRY

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BAYRY

STOCK Act disclosures

Loading…

SEC filings & insiders · BAYRY

EDGAR · live

Loading…

Holders · BAYRY

Institutions & insider activity

Loading…